{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:14:45Z","timestamp":1791339285350,"version":"4.3.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vaccine.2025.127307","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:02:14Z","timestamp":1748293334000},"page":"127307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunogenicity evaluation of a recombinant pseudorabies virus co-expressing PCV2 and PCV3 capsid proteins in mice and piglets"],"prefix":"10.1016","volume":"60","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunDa","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127307_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127307_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1865-1682.2011.01288.x","article-title":"Porcine circovirus diseases: a review of PMWS","volume":"59","author":"Baekbo","year":"2012","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13567-022-01029-w","article-title":"A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines","volume":"53","author":"Bandrick","year":"2022","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13567-023-01181-x","article-title":"A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission","volume":"54","author":"Chen","year":"2023","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1743-422X-8-307","article-title":"A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: immunogenicity and protective efficacy in swine","volume":"8","author":"Chen","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.127307_bb0030","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1084\/jem.20181031","article-title":"CNBP controls IL-12 gene transcription and Th1 immunity","volume":"215","author":"Chen","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.127307_bb0035","series-title":"Seminars in immunopathology","first-page":"517","article-title":"Cytokine storm and sepsis disease pathogenesis","author":"Chousterman","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127307_bb0040","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00018-019-03117-1","article-title":"Progress on chicken T cell immunity to viruses","volume":"76","author":"Dai","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2025.127307_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/824630","article-title":"An overview of live attenuated recombinant pseudorabies viruses for use as novel vaccines","volume":"2014","author":"Dong","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0050","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3389\/fmicb.2019.02050","article-title":"Interleukin-10 promotes porcine circovirus type 2 persistent infection in mice and aggravates the tissue lesions by suppression of t cell infiltration","volume":"10","author":"Du","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0300985814521245","article-title":"Porcine circovirus: a historical perspective","volume":"51","author":"Ellis","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11259-007-3469-7","article-title":"Immunogenicity of empty capsids of porcine circovius type 2 produced in insect cells","volume":"31","author":"Fan","year":"2007","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2025.127307_bb0065","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.01719-09","article-title":"Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2","volume":"83","author":"Firth","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vetmic.2016.11.019","article-title":"Vaccines against pseudorabies virus (PrV)","volume":"206","author":"Freuling","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1054\/tube.2000.0271","article-title":"Optimal models to evaluate the protective efficacy of tuberculosis vaccines","volume":"81","author":"Griffin","year":"2001","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0080","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0169-409X(02)00072-8","article-title":"A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery","volume":"54","author":"Griffin","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2025.127307_bb0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0966-842X(00)88994-5","article-title":"Animal models of protective immunity in tuberculosis to evaluate candidate vaccines","volume":"3","author":"Griffin","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0090","first-page":"221","article-title":"Emergence of highly virulent pseudorabies virus in southern China","volume":"79","author":"Gu","year":"2015","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1354\/vp.38-5-528","article-title":"Experimental reproduction of severe disease in CD\/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus","volume":"38","author":"Harms","year":"2001","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10529-007-9459-6","article-title":"A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate","volume":"29","author":"Hong","year":"2007","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2025.127307_bb0105","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.vaccine.2016.02.047","article-title":"Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B","volume":"34","author":"Hu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127307_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12917-023-03739-5","article-title":"Intranasal administration with recombinant vaccine PRVXJ-delgE\/gI\/TK-S induces strong intestinal mucosal immune responses against PDCoV","volume":"19","author":"Huang","year":"2023","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01836-19","article-title":"Neutralization mechanism of a monoclonal antibody targeting a porcine circovirus type 2 cap protein conformational epitope","volume":"94","author":"Huang","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0120","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.vaccine.2006.07.032","article-title":"Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus","volume":"25","author":"Jiang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127307_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/v16101580","article-title":"Construction and immunogenicity of a recombinant porcine pseudorabies virus (PRV) expressing the major neutralizing epitope regions of S1 protein of variant PEDV","volume":"16","author":"Jiao","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127307_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetmic.2005.06.001","article-title":"Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2","volume":"109","author":"Ju","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tbed.12276","article-title":"Emergence of porcine circovirus 2 associated reproductive failure in southern India","volume":"63","author":"Karuppannan","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2009.07.007","article-title":"Functional roles of the tegument proteins of herpes simplex virus type 1","volume":"145","author":"Kelly","year":"2009","journal-title":"Virus Res"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2025.127307_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1099\/0022-1317-73-2-243","article-title":"Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity","volume":"73","author":"Kimman","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fvets.2018.00315","article-title":"Current knowledge on porcine circovirus 3 (PCV-3): a novel virus with a yet unknown impact on the swine industry","volume":"5","author":"Klaumann","year":"2018","journal-title":"Frontiers in veterinary science"},{"key":"10.1016\/j.vaccine.2025.127307_bb0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/JVI.78.1.424-440.2004","article-title":"Complete, annotated sequence of the pseudorabies virus genome","volume":"78","author":"Klupp","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gene.2015.04.055","article-title":"Differential recognition of the ORF2 region in a complete genome sequence of porcine circovirus type 2 (PCV2) isolated from boar bone marrow in Korea","volume":"569","author":"Kweon","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2025.127307_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2016.11.015","article-title":"Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population","volume":"228","author":"Kwon","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01614-18","article-title":"Virulent pseudorabies virus infection induces a specific and lethal systemic inflammatory response in mice","volume":"92","author":"Laval","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2018.07.014","article-title":"Production of a monoclonal antibody against porcine circovirus type 3 cap protein","volume":"261","author":"Li","year":"2018","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2025.127307_bb0185","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.vaccine.2008.03.020","article-title":"Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus","volume":"26","author":"Li","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127307_bb0190","doi-asserted-by":"crossref","first-page":"e3690","DOI":"10.1093\/cid\/ciaa987","article-title":"A novel human acute encephalitis caused by pseudorabies virus variant strain","volume":"73","author":"Liu","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/prep.2000.1356","article-title":"Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein","volume":"21","author":"Liu","year":"2001","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2025.127307_bb0200","doi-asserted-by":"crossref","first-page":"1438371","DOI":"10.3389\/fimmu.2024.1438371","article-title":"Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded cap protein of circovirus","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0205","first-page":"1815","article-title":"Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes","volume":"81","author":"Mah\u00e9","year":"2000","journal-title":"J Gen Virol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2025.127307_bb0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/0022-1317-79-2-381","article-title":"Identification of a protein essential for replication of porcine circovirus","volume":"79","author":"Mankertz","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-4320(00)00135-4","article-title":"The effect of porcine parvovirus and porcine reproductive and respiratory syndrome virus on porcine reproductive performance","volume":"60-61","author":"Mengeling","year":"2000","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.vaccine.2025.127307_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/viro.1993.1008","article-title":"Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV","volume":"192","author":"Meulenberg","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127307_bb0225","first-page":"33","article-title":"Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV","volume":"9","author":"Nawagitgul","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0230","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1099\/0022-1317-81-9-2281","article-title":"Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein","volume":"81","author":"Nawagitgul","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005997","article-title":"The impact of the gut microbiota on humoral immunity to pathogens and vaccination in early infancy","volume":"12","author":"Nguyen","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127307_bb0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2011.04.039","article-title":"Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing toxoplasma gondii SAG1 and MIC3 proteins","volume":"181","author":"Nie","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0245","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00352-06","article-title":"Role of pseudorabies virus Us3 protein kinase during neuronal infection","volume":"80","author":"Olsen","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","article-title":"Concurrent infections are important for expression of porcine circovirus associated disease","volume":"164","author":"Opriessnig","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198044","article-title":"Porcine circoviruses: current status, knowledge gaps and challenges","volume":"286","author":"Opriessnig","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0260","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/104063870701900601","article-title":"Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies","volume":"19","author":"Opriessnig","year":"2007","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2025.127307_bb0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/v11020185","article-title":"Co-infection of swine with porcine circovirus type 2 and other swine viruses","volume":"11","author":"Ouyang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127307_bb0270","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01879-16","article-title":"A novel porcine circovirus distantly related to known circoviruses is associated with porcine dermatitis and nephropathy syndrome and reproductive failure","volume":"91","author":"Palinski","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12985-017-0756-y","article-title":"Erratum to: detection of a novel circovirus PCV3 in pigs with cardiac and multi-systemic inflammation","volume":"14","author":"Phan","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.127307_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/vim.2000.13.143","article-title":"Characterization of immune response of young pigs to porcine circovirus type 2 infection","volume":"13","author":"Pogranichnyy","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0285","doi-asserted-by":"crossref","first-page":"8858447","DOI":"10.1155\/2023\/8858447","article-title":"Porcine circovirus type 3: diagnostics, genotyping, and challenges in vaccine development","volume":"2023","author":"Pranoto","year":"2023","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134955","article-title":"Efficacy comparison in cap VLPs of PCV2 and PCV3 as swine vaccine vehicle","volume":"278","author":"Qiu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0295","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gene.2017.09.058","article-title":"Molecular study of porcine circovirus type 2 in wild boars and domestic pigs in Uruguay from 2010 to 2014: predominance of recombinant circulating strains","volume":"637","author":"Ramos","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2025.127307_bb0300","doi-asserted-by":"crossref","first-page":"6104054","DOI":"10.1155\/2017\/6104054","article-title":"IL-10: a multifunctional cytokine in viral infections","volume":"2017","author":"Rojas","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1746-6148-7-64","article-title":"Outcome of experimental porcine circovirus type 1 infections in mid-gestational porcine foetuses","volume":"7","author":"Saha","year":"2011","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","article-title":"Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis","volume":"164","author":"Segal\u00e9s","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0315","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s00705-014-2164-6","article-title":"Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea","volume":"159","author":"Seo","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0320","first-page":"377","article-title":"Antigenic analysis of the recombinant capsid protein of porcine circovirus type 2. Wei sheng wu xue bao=","volume":"45","author":"Shang","year":"2005","journal-title":"Acta Microbiol Sin"},{"key":"10.1016\/j.vaccine.2025.127307_bb0325","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1093\/clinids\/11.Supplement_2.S385","article-title":"What animal models can teach us about the pathogenesis of tuberculosis in humans","volume":"11","author":"Smith","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.vetmic.2006.08.026","article-title":"Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2","volume":"119","author":"Song","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0335","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vetmic.2015.12.008","article-title":"Control of swine pseudorabies in China: opportunities and limitations","volume":"183","author":"Sun","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0345","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12250-020-00340-0","article-title":"Current status and challenge of pseudorabies virus infection in China","volume":"36","author":"Tan","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2025.127307_bb0350","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetmic.2017.08.006","article-title":"Genetic diversity of porcine circovirus type 2 (PCV2) in Thailand during 2009-2015","volume":"208","author":"Thangthamniyom","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vetimm.2006.01.015","article-title":"A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge","volume":"111","author":"Tian","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0360","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.vaccine.2014.04.035","article-title":"A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127307_bb0365","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetmic.2006.11.027","article-title":"Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2","volume":"121","author":"Wang","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0370","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.vaccine.2005.12.068","article-title":"Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127307_bb0375","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/01652176.2000.9695049","article-title":"Isolation and characterization of porcine circovirus type 2 from pigs showing signs of post-weaning multisystemic wasting syndrome in the Netherlands","volume":"22","author":"Wellenberg","year":"2000","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2025.127307_bb0380","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1099\/vir.0.000100","article-title":"Global molecular genetic analysis of porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d","volume":"96","author":"Xiao","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0385","doi-asserted-by":"crossref","first-page":"1339387","DOI":"10.3389\/fimmu.2024.1339387","article-title":"Construction of recombinant pseudorabies virus expressing PCV2 cap, PCV3 cap, and IL-4: investigation of their biological characteristics and immunogenicity","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127307_bb0390","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12917-019-1859-z","article-title":"Genetic analysis of porcine circovirus type 2 (PCV2) strains between 2002 and 2016 reveals PCV2 mutant predominating in porcine population in Guangxi","volume":"15","author":"Yao","year":"2019","journal-title":"China BMC Vet Res"},{"key":"10.1016\/j.vaccine.2025.127307_bb0395","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11262-018-1582-z","article-title":"First detection and full genome sequence of porcine circovirus type 3 in Russia","volume":"54","author":"Yuzhakov","year":"2018","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2025.127307_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fvets.2019.00319","article-title":"Reservoirs of porcine circoviruses: a Mini review","volume":"6","author":"Zhai","year":"2019","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2025.127307_bb0405","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/tbed.13446","article-title":"Novel circovirus species identified in farmed pigs designated as porcine circovirus 4, Hunan province, China","volume":"67","author":"Zhang","year":"2020","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2025.127307_bb0410","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12985-020-1292-8","article-title":"Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6","volume":"17","author":"Zheng","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.127307_bb0415","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.vaccine.2017.01.003","article-title":"Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus","volume":"35","author":"Zhou","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:19:09Z","timestamp":1749122349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":83,"alternative-id":["S0264410X25006048"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127307","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity evaluation of a recombinant pseudorabies virus co-expressing PCV2 and PCV3 capsid proteins in mice and piglets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127307"}}